Increase of insulin secretion by ginsenoside Rh2 to lower plasma glucose in Wistar rats

Clinical and Experimental Pharmacology and Physiology

Volumn 33, Issue 1-2, 2006, Pages 27-32

  Lee, Wen Kung ^a   Kao, Shung Te ^a   Liu, I Min ^b   Cheng, Juei Tang ^c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b TAJEN INSTITUTE OF TECHNOLOGY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Acetylcholine; Ginsenosides Rh2; Insulin; Muscarinic M3 receptors; Wistar rats

Indexed keywords

ACETYLCHOLINESTERASE; ATROPINE; GINSENG EXTRACT; GINSENOSIDE; HEMICHOLINIUM 3; HEXAMETHONIUM; PENTOLONIUM TARTRATE; PHYSOSTIGMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RELEASE; MALE; NERVE ENDING; NONHUMAN; RAT; SYNAPTIC TRANSMISSION;

ANIMALS; ATROPINE; BLOOD GLUCOSE; C-PEPTIDE; CHOLINERGIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GINSENOSIDES; HEMICHOLINIUM 3; INJECTIONS, INTRAVENOUS; INSULIN; MALE; MUSCARINIC ANTAGONISTS; NEUROMUSCULAR DEPOLARIZING AGENTS; PIPERIDINES; RATS; RATS, WISTAR;

EID: 33645083467     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2006.04319.x     Document Type: Article

References (38)

1. Kennedy DO Scholey AB Ginseng: Potential for the enhancement of cognitive performance and mood PharmacolBiochemBehav 2003 75 687 700
2. Block KI Mead MN Immune system effects of echinacea, ginseng, and astragalus: A review IntegrCancer Ther 2003 2 247 67
3. Van Kampen J Robertson H Hagg T Drobitch R Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease ExpNeurol 2003 184 521 9
4. Huang KC The Pharmacology of Chinese Herbs CRC Press Boca Raton, FL 1999
5. Lee FC Facts About Ginseng, The Elixir of Life Hollyn International Elizabeth, NJ 1992
6. Kimura M Waki I Tanaka O Nagai Y Shibata S Pharmacological sequential trials for the fractionation of components with hypoglycemic activity in alloxan diabetic mice from ginseng radix JPharmacobiodyn 1981 4 402 9
7. y mice JPharmacobiodyn 1981 4 907 15
8. 2 in streptozotocin diabetic rats ChemPharmBull 1985 33 869 72
9. Sotaniemi EA Haapakoski E Rautio A Ginseng therapy in non-insulin-dependent diabetic patients Diabetes Care 1995 18 1373 5
10. Vuksan V Sievenpiper JL Wong J et al. American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time-dependent but not dose-dependent manner in healthy individuals AmJClinNutr 2001 73 753 8
11. Kahn SE Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes JClinEndocrinolMetab 2001 86 4047 58
12. Kahn CR Banting lecture: Insulin action, diabetogenes, and the cause of type 2 diabetes Diabetes 1994 43 1066 84
13. Korytkowski MT Sulfonylurea treatment of type 2 diabetes mellitus: Focus on glimepiride Pharmacotherapy 2004 24 606 20
14. Liu TP Liu IM Cheng JT Improvement of insulin resistance by Panax ginseng in fructose-rich chow-fed rats HormMetabRes 2005 37 146 51
15. Kiefer D Pantuso T Panax ginseng AmFamPhysician 2003 68 1539 42
16. Chen XC Zhu YG Zhu LA et al. Ginsenoside Rg1 attenuates dopamine-induced apoptosis in PC12 cells by suppressing oxidative stress EurJPharmacol 2003 473 1 7
17. Keum YS Han SS Chun KS et al. Inhibitory effects of the ginsenoside Rg3 on phorbol ester-induced cyclooxygenase-2 expression, NF-kappaB activation and tumor promotion MutatRes 2003 523-524 75 85
18. Bae EA Han MJ Choo MK Park SY Kim DH Metabolism of 20(S)- and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities BiolPharmBull 2002 25 58 63
19. Popovich DG Kitts DD Structure-function relationship exists for ginsenosides in reducing cell proliferation and inducing apoptosis in the human leukemia (THP-1) cell line ArchBiochemBiophys 2002 406 1 8
20. Cheng JT Liu IM Chi TC Su HC Chang CG Stimulation of insulin release in rats by Die-Huang-Wan, a herbal mixture used in Chinese traditional medicine JPharmPharmacol 2001 53 273 6
21. Polonsky KS Pugh W Jaspan JB et al. C-Peptide and insulin secretion. Relationship between peripheral concentrations of C-peptide and insulin and their secretion rates in the dog JClinInvest 1984 74 1821 9
22. Ahren B Autonomic regulation of islet hormone secretion: Implications for health and disease Diabetologia 2000 43 393 410
23. Gilon P Henquin JC Mechanisms and physiological significance of the cholinergic control of pancreatic beta-cell function EndocrRev 2001 22 565 604
24. Free RB McKay DB Receptor protection studies to characterize neuronal nicotinic receptors: Tubocurarine prevents alkylation of adrenal nicotinic receptors Brain Res 2001 891 176 84
25. Wess J Molecular biology of muscarinic acetylcholine receptors CritRevNeurobiol 1996 10 69 99
26. Nathanson NM Molecular properties of the muscarinic acetylcholine receptor AnnuRevNeurosci 1987 10 195 236
27. 3 muscarinic receptors AmJPhysiol 1995 268 E336 42
28. Tang SH Sharp GW Identification of muscarinic receptor subtypes in RINm5F cells by means of polymerase chain reaction, subcloning, and DNA sequencing Diabetes 1997 46 1419 23
29. Iismaa TP Kerr EA Wilson JR Carpenter L Sims N Biden TJ Quantitative and functional characterization of muscarinic receptor subtypes in insulinsecreting cell lines and rat pancreatic islets Diabetes 2000 49 392 8
30. 3 muscarinic acetylcholine receptor-deficient mice Diabetes 2004 53 1714 20
31. Barlow RB McMillen LS Veale MA The use of 4-diphenylacetoxy-N-(2- chloroethyl)-piperidine (4-DAMP mustard) for estimating the apparent affinities of some agonists acting at muscarinic receptors in guinea-pig ileum BrJPharmacol 1991 102 657 62
32. Anderson DC King SC Parsons SM Pharmacological characterization of the acetylcholine transport system in purified Torpedo electric organ synaptic vesicles MolPharmacol 1983 24 48 54
33. Naves LA Van der Kloot W Transmitter packaging at frog neuromuscular junctions exposed to anticholinesterases: The role of second-stage acetylcholine loading JNeurophysiol 1996 76 2614 25
34. Prado MA Gomez MV Collier B Mobilization of the readily releasable pool of acetylcholine from a sympathetic ganglion by tityustoxin in the presence of vesamicol JNeurochem 1992 59 544 52
35. Aquilonius SM Hartvig P Clinical pharmacokinetics of cholinesterase inhibitors ClinPharmacokinet 1986 11 236 49
36. Fischbach GD Frank E Jessell TM Rubin LL Schuetze SM Accumulation of acetylcholine receptors and acetylcholinesterase at newly formed nerve-muscle synapses PharmacolRev 1978 30 411 28
37. Nakata H Kikuchi Y Tode T et al. Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells JpnJCancer Res 1998 89 733 40
38. Hasegawa H Lee KS Nagaoka T et al. Pharmacokinetics of ginsenoside deglycosylated by intestinal bacteria and its transformation to biologically active fatty acid esters BiolPharmBull 2000 23 298 304